NORTON CANES PRACTICE — All Prescriptions & Medications — Page 5
Practice Code: M83727 | CANNOCK, WS11 9SE
Showing results 201-250 of 437
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Ivabradine | 57 | 5,600 | £1.7K | -40.0% ▼ |
| Oxybutynin | 56 | 5,040 | £269 | -70.6% ▼ |
| Promethazine hydrochloride | 55 | 2,058 | £282 | -84.6% ▼ |
| Dorzolamide | 55 | 2,820 | £1.1K | -33.8% ▼ |
| Lorazepam | 53 | 1,974 | £384 | -62.8% ▼ |
| Bimatoprost | 53 | 981 | £590 | -64.3% ▼ |
| 52 | 615 | £287 | -79.2% ▼ | |
| Cyclizine hydrochloride | 51 | 2,920 | £101 | -68.4% ▼ |
| Verapamil hydrochloride | 50 | 3,976 | £458 | -44.9% ▼ |
| Canagliflozin | 50 | 2,768 | £3.4K | -65.2% ▼ |
| Alfacalcidol | 50 | 2,184 | £277 | -59.6% ▼ |
| 49 | 455 | £157 | -76.6% ▼ | |
| Acetylcysteine | 48 | 1,680 | £293 | -32.9% ▼ |
| Mirabegron | 48 | 2,100 | £1.9K | -88.1% ▼ |
| Sodium bicarbonate | 48 | 5,788 | £258 | -48.1% ▼ |
| 48 | 4,980 | £9.2K | -1.5% vs avg | |
| Isophane insulin | 46 | 214 | £941 | -56.4% ▼ |
| Miconazole nitrate | 46 | 1,720 | £261 | -35.0% ▼ |
| Umeclidinium bromide/vilanterol | 45 | 68 | £2.1K | -76.9% ▼ |
| Docusate sodium | 44 | 4,290 | £294 | -88.1% ▼ |
| Amiodarone hydrochloride | 44 | 1,437 | £77 | -31.8% ▼ |
| Timolol and bimatoprost | 44 | 384 | £900 | -71.0% ▼ |
| Fusidic acid | 44 | 675 | £91 | -65.5% ▼ |
| Moxonidine | 43 | 3,304 | £481 | -22.8% ▼ |
| Glycopyrronium bromide | 42 | 1,630 | £1.4K | +12.7% ▲ |
| Fluticasone furoate/vilanterol | 42 | 57 | £1.4K | -72.9% ▼ |
| Clonidine hydrochloride | 42 | 12.4K | £17.3K | -21.3% ▼ |
| Azathioprine | 42 | 3,988 | £102 | -61.2% ▼ |
| Other individually formulated bought in preparations | 42 | 654 | £226 | +28.6% ▲ |
| Escitalopram | 41 | 1,302 | £77 | -85.6% ▼ |
| Risperidone | 40 | 1,072 | £288 | -84.2% ▼ |
| Topiramate | 40 | 2,796 | £834 | -77.5% ▼ |
| Ropinirole hydrochloride | 40 | 2,856 | £1.7K | -62.3% ▼ |
| Methenamine hippurate | 40 | 2,820 | £882 | -56.0% ▼ |
| Powder extensively hydrolysed formula (0913101) | 40 | 82.4K | £2.4K | -44.5% ▼ |
| Aripiprazole | 39 | 504 | £100 | -84.7% ▼ |
| Clobetasol propionate | 39 | 3,220 | £249 | -71.4% ▼ |
| Clobetasone butyrate | 39 | 2,170 | £263 | -80.9% ▼ |
| 39 | 980 | £358 | -49.6% ▼ | |
| Leflunomide | 38 | 1,140 | £712 | +0.4% vs avg |
| Carvedilol | 37 | 3,010 | £110 | -67.4% ▼ |
| Orlistat | 37 | 6,300 | £1.4K | -55.1% ▼ |
| Donepezil hydrochloride | 37 | 1,540 | £54 | -88.0% ▼ |
| Semaglutide | 37 | 90 | £4.5K | -84.6% ▼ |
| Febuxostat | 37 | 1,652 | £154 | -0.9% vs avg |
| Co-beneldopa (Benserazide/levodopa) | 36 | 5,300 | £341 | -76.2% ▼ |
| Pioglitazone hydrochloride | 36 | 1,568 | £78 | -59.3% ▼ |
| Other multivitamin preparations | 36 | 2,070 | £723 | -79.2% ▼ |
| Fluticasone propionate (Nasal) | 36 | 272 | £434 | -75.3% ▼ |
| Famotidine | 35 | 1,596 | £989 | -92.8% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.